Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.3.23 (
GAS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CD94
is a C-type lectin required for the dimerization of the
CD94
/NKG2 family of receptors, which are expressed on NK cells and T cell subsets. Little is known about
CD94
gene expression and the elements that regulate
CD94
transcription. In this study, we report that
CD94
gene expression is regulated by distal and proximal promoters that transcribe unique initial exons specific to each promoter. This results in two species of transcripts; the previously described
CD94
mRNA and a novel CD94C mRNA. All NK cells and
CD94
(+), CD8(+) alphabeta T cells transcribe
CD94
mRNA. Stimulation of NK and CD8(+) alphabeta T cells with IL-2 or IL-15 induced the transcription of CD94C mRNA. The distal and proximal promoters both contain elements with IFN-gamma-activated and Ets binding sites, known as
GAS
/EBS. Additionally, an unknown element, termed site A, was identified in the proximal promoter. EMSA analyses showed that constitutive factors could bind to oligonucleotide probes containing each element. After treatment of primary NK cells with IL-2 or IL-15, separate inducible complexes could be detected with oligonucleotide probes containing either the proximal or distal
GAS
/EBS elements. These elements are highly conserved between mice and humans, which suggests that both species regulate
CD94
gene expression via mechanisms that predate their evolutionary divergence.
...
PMID:Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15. 1460 29